DK0551729T3 - gamma-linolensyre til fremstilling af et medikament til forhindring af reokklusion af arterier - Google Patents

gamma-linolensyre til fremstilling af et medikament til forhindring af reokklusion af arterier

Info

Publication number
DK0551729T3
DK0551729T3 DK92310807.0T DK92310807T DK0551729T3 DK 0551729 T3 DK0551729 T3 DK 0551729T3 DK 92310807 T DK92310807 T DK 92310807T DK 0551729 T3 DK0551729 T3 DK 0551729T3
Authority
DK
Denmark
Prior art keywords
medicament
gamma
linolenic acid
manufacture
preventing arterial
Prior art date
Application number
DK92310807.0T
Other languages
English (en)
Inventor
David Frederick Horrobin
John Charles Stewart
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Application granted granted Critical
Publication of DK0551729T3 publication Critical patent/DK0551729T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Control Of Turbines (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Amplifiers (AREA)
  • Control Of Motors That Do Not Use Commutators (AREA)
  • Glass Compositions (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Drying Of Semiconductors (AREA)
  • Semiconductor Lasers (AREA)
DK92310807.0T 1991-12-02 1992-11-26 gamma-linolensyre til fremstilling af et medikament til forhindring af reokklusion af arterier DK0551729T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919125602A GB9125602D0 (en) 1991-12-02 1991-12-02 Method of preventing reocclusion of arteries

Publications (1)

Publication Number Publication Date
DK0551729T3 true DK0551729T3 (da) 1996-02-12

Family

ID=10705559

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92310807.0T DK0551729T3 (da) 1991-12-02 1992-11-26 gamma-linolensyre til fremstilling af et medikament til forhindring af reokklusion af arterier

Country Status (17)

Country Link
US (2) US5378732A (da)
EP (2) EP0551729B1 (da)
JP (1) JPH05286854A (da)
KR (1) KR930012009A (da)
AT (1) ATE133334T1 (da)
AU (2) AU657009B2 (da)
CA (1) CA2084273A1 (da)
DE (1) DE69207885T2 (da)
DK (1) DK0551729T3 (da)
ES (1) ES2082390T3 (da)
GB (1) GB9125602D0 (da)
GR (1) GR3019270T3 (da)
HK (1) HK131096A (da)
NO (1) NO303047B1 (da)
NZ (1) NZ245343A (da)
TW (1) TW223589B (da)
ZA (1) ZA929316B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824644A (en) * 1994-07-07 1998-10-20 G. D. Searle & Co. Method of attenuating arterial stenosis
GB0016045D0 (en) * 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
JP2002047176A (ja) * 2000-08-04 2002-02-12 Idemitsu Technofine Co Ltd ＩｇＥ産生抑制剤
ITMI20012384A1 (it) * 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
US7098352B2 (en) * 2001-11-16 2006-08-29 Virtus Nutrition Llc Calcium salt saponification of polyunsaturated oils
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
AU2005241033A1 (en) * 2004-04-30 2005-11-17 Virtus Nutrition Llc Polyunsaturated fatty acid monovalent and divalent metal salt synthesis
WO2008088030A1 (ja) * 2007-01-17 2008-07-24 Mochida Pharmaceutical Co., Ltd. 血栓もしくは塞栓に関連する疾患の予防又は治療用組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1240513A (en) * 1968-09-13 1971-07-28 Ono Pharmaceutical Co Poly-unsaturated fatty acid ester composition and its preparation
GB1580444A (en) * 1976-11-04 1980-12-03 Bio Oil Res Pharmaceutical compositions
US4526902A (en) * 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
JPS60132916A (ja) * 1983-12-21 1985-07-16 Nisshin Oil Mills Ltd:The 血栓症予防食品または医薬品
IT1176916B (it) * 1984-10-10 1987-08-18 Elvira Pistolesi Composizione farmaceutica o dietetica ad elevata attivita' antitrombotica e antiarteriosclerotica
US4920098A (en) * 1986-09-17 1990-04-24 Baxter International Inc. Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic vascular, cardiovascular, and/or thrombotic diseases
US5059622A (en) * 1989-08-29 1991-10-22 Biosyn, Inc. Method for reducing blood pressure levels in hypertensive persons
GB8916734D0 (en) * 1989-07-21 1989-09-06 Efamol Holdings Pharmaceutical and dietary uses of fatty acids

Also Published As

Publication number Publication date
KR930012009A (ko) 1993-07-20
ATE133334T1 (de) 1996-02-15
ZA929316B (en) 1993-09-09
EP0676197A3 (en) 1996-09-11
NO303047B1 (no) 1998-05-25
US5859055A (en) 1999-01-12
EP0551729A1 (en) 1993-07-21
AU1656395A (en) 1995-06-29
US5378732A (en) 1995-01-03
DE69207885T2 (de) 1996-07-25
JPH05286854A (ja) 1993-11-02
DE69207885D1 (de) 1996-03-07
NO924637D0 (no) 1992-12-01
HK131096A (en) 1996-07-26
ES2082390T3 (es) 1996-03-16
AU2968792A (en) 1993-06-03
AU680725B2 (en) 1997-08-07
NO924637L (no) 1993-06-03
EP0551729B1 (en) 1996-01-24
NZ245343A (en) 1997-06-24
AU657009B2 (en) 1995-02-23
GB9125602D0 (en) 1992-01-29
GR3019270T3 (en) 1996-06-30
TW223589B (da) 1994-05-11
CA2084273A1 (en) 1993-06-03
EP0676197A2 (en) 1995-10-11

Similar Documents

Publication Publication Date Title
DE3669103D1 (de) Ibuprofen enthaltendes arzneimittel.
AU562938B2 (en) 7, 10, 13, 16 docosatetraenoic acid composition
DE68923819D1 (de) Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen.
SE8803472D0 (sv) Anvaendning av gamma-interferon foer behandling av vaskulaer stenos
FI940659A0 (fi) Heterosyklisesti substituoituja fenyylisykloheksaanikarboksyylihappojohdannaisia
DE69202019D1 (de) Verwendung von essentiellen Fettsäuren zur Herstellung eines Arzneimittels zur Behandlung von AIDS.
ZA906187B (en) Pharmaceutical compositions
DE3875286D1 (de) Essentielle fettsaeure enthaltende zusammensetzungen.
DK399288A (da) Dobbeltstrenget rna-korrektion af abnormiteter i cirkulerende immunkomplekser og monocytfunktion
DK0458287T3 (da) Anvendelse af magnesium-pyridoxal-5-phosphat-glutaminat til forebyggelse af sygdomme forårsaget af vaskulære læsioner
DK0551729T3 (da) gamma-linolensyre til fremstilling af et medikament til forhindring af reokklusion af arterier
DE68912432D1 (de) Pharmazeutische Zusammensetzung, verwendbar bei der Behandlung von Herzgefässerkrankungen.
DK417889A (da) Anvendelse af 2-azabicyklo(2.2.2.)-carboxylsyrederivater til fremstilling af medicinske produkter til behandling af vaskulaere sygdomme
FR2669826B1 (fr) Catheter pour la dilatation des arteres.
IT8735615V0 (it) Giuoco da tavolo basato sull'ominimia delle parole
ATE78823T1 (de) 1,4-dihydro-5-isopropoxy-2-methyl-4-(2trifluormethyl-phenyl)-1,6-naphthyridin-3de890301
DK448289D0 (da) Kombineret behandling af arteria femoralis superficialis okklusion med perkutan transluminal angioplastik og lokalt indelukket rekombineret plasminogen aktivator 4 lumen eller flere lumina med 2 ellerflere balloner paa kateteret